Background-Atrial fibrillation (AF) is commonly associated with congestive heart failure (CHF). The autonomic nervous system is involved in the pathogenesis of both AF and CHF. We examined the role of autonomic remodeling in contributing to AF substrate in CHF. Methods and Results-Electrophysiological mapping was performed in the pulmonary veins and left atrium in 38 rapid ventricular-paced dogs (CHF group) and 39 control dogs under the following conditions: vagal stimulation, isoproterenol infusion, ␤-adrenergic blockade, acetylcholinesterase (AChE) inhibition (physostigmine), parasympathetic blockade, and double autonomic blockade. Explanted atria were examined for nerve density/distribution, muscarinic receptor and ␤-adrenergic receptor densities, and AChE activity. In CHF dogs, there was an increase in nerve bundle size, parasympathetic fibers/bundle, and density of sympathetic fibrils and cardiac ganglia, all preferentially in the posterior left atrium/pulmonary veins. Sympathetic hyperinnervation was accompanied by increases in ␤ 1 -adrenergic receptor R density and in sympathetic effect on effective refractory periods and activation direction. ␤-Adrenergic blockade slowed AF dominant frequency. Parasympathetic remodeling was more complex, resulting in increased AChE activity, unchanged muscarinic receptor density, unchanged parasympathetic effect on activation direction and decreased effect of vagal stimulation on effective refractory period (restored by AChE inhibition). Parasympathetic blockade markedly decreased AF duration. Conclusions-In this heart failure model, autonomic and electrophysiological remodeling occurs, involving the posterior left atrium and pulmonary veins. Despite synaptic compensation, parasympathetic hyperinnervation contributes significantly to AF maintenance. Parasympathetic and/or sympathetic signaling may be possible therapeutic targets for AF in CHF. (Circ Arrhythm Electrophysiol. 2011;4:388-396.)
A trial fibrillation (AF) is commonly seen in patients with congestive heart failure (CHF). 1 Coexistence of AF and CHF results in increased morbidity and mortality as compared with either condition alone. 2 A variety of structural and electrophysiological changes in the atria contribute to the increased susceptibility to AF in the setting of CHF. 3, 4 Changes in ion channel expression and gap junction distribution, structural remodeling in the form of fibrosis, and oxidative stress are some of the mechanisms that contribute to AF substrate in the setting of CHF. [3] [4] [5] In addition, in both clinical and experimental studies, AF has been shown to be mediated at least in part by the autonomic nervous system. 6, 7 It is likely that no single pathophysiological mechanism in and of itself is sufficient to create adequate AF substrate in the CHF setting, with a combination of mechanisms being required to create conditions for the genesis and maintenance of AF. Although the role of ion channel remodeling and fibrosis has been studied extensively in the creation of AF substrate in CHF, the specific contribution of the autonomic nervous system to AF in the setting of CHF has not been well elucidated.
Clinical Perspective on p 396
Parasympathetic and sympathetic stimulation have both been demonstrated to be proarrhythmic in the atrium, through refractory period shortening and increased heterogeneity of repolarization. 8 Our previous studies have shown the posterior left atrium (PLA) and pulmonary veins (PVs) have a unique autonomic profile that could help sustain AF in the normal heart. 9 How autonomic effects on atrial electrophysiology are altered by CHF is not completely understood. There is evidence of sympathetic hyperinnervation in patients with AF. 10 Although it has recently been suggested that there are increased vagal and sympathetic discharges in CHF that may provide the triggers of AF, 11, 12 the precise nature of autonomic remodeling in AF and its potential role in the creation of AF substrate in CHF have not been studied. We therefore examined in detail structure-function relationships regarding the nature of sympathetic as well as parasympathetic remodeling in the left atrium and PVs during CHF. Our results indicate that autonomic remodeling is not only complex but is strikingly different in the atrium, from what has been reported in the ventricle in the setting of CHF, with the parasympathetic nervous system playing an important role in the creation of AF substrate (unlike in the ventricle, where the vagus appears to be protective against arrhythmias). Sympathetic changes in the CHF atrium also differed from the failing ventricle, 13, 14 with both sympathetic nerves and ␤-receptors being upregulated in the atrium.
Methods
Additional methodological details for each of the sections below are described in the online-only Data Supplement.
Canine CHF Model
Thirty-eight purpose-bred hound dogs were used. The details of the pacing model are as previously described. 4, 5 In each dog, sterile surgery for pacemaker implantation was performed. The pacemaker was programmed to pace the right ventricle at a rate of 240 beats per minute. In the first 10 dogs, left ventricular function was assessed during pacing by serial echocardiograms (results for these 10 animals are shown in online-only Data Supplement Figure 1 ) and clinical symptomology (ascites, tachypnea, reduced physical activity). CHF, indicated by compromised left ventricular function, was confirmed at 3 weeks of pacing. Thirty-nine control dogs (ie, not paced) were studied for comparison. This protocol conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the Animal Care and Use Committee of Northwestern University.
Experimental Setup
Immediately after the 3 weeks of rapid ventricular pacing, a median sternotomy was performed under general anesthesia with isoflurane. High-density plaques were applied to the left inferior PV (PV; 8ϫ5 electrodes; 2.5-mm spacing), the posterior left atrium (PLA; 7ϫ3 electrodes, 5-mm spacing), and the left atrial appendage (LAA; 7ϫ3 electrodes, 5-mm spacing) for bipolar electrogram recordings and pacing. The PV plaque was placed circumferentially around the vein, whereas the other 2 plaques were laid flat on the PLA and LAA epicardium. The left cervical Vagus nerve was isolated and attached with bipolar electrodes for electric stimulation.
Autonomic Maneuvers
Effective refractory period (ERP) measurement, activation mapping, and arrhythmia induction (to be described) were performed at baseline and in the presence of the parasympathetic and sympathetic maneuvers described below.
Autonomic Blockade
Autonomic blockade consisted of (1) complete parasympathetic blockade with atropine (0.04 mg/kg) 15 ; (2) ␤-adrenergic blockade with propranolol (0.2 mg/kg) 15 ; and (3) double autonomic blockade with propranolol (0.2 mg/kg) and atropine (0.04 mg/kg).
Autonomic Stimulation
Autonomic stimulation consisted of (1) electric stimulation of the isolated left cervical Vagus nerve with a stimulation rate of 20 Hz, pulse width of 5 ms, and amplitude of 10 V (Grass S44G, Astromed, West Warwick, Rhode Island); (2) acetylcholinesterase (AChE) inhibition through intravenous physostigmine infusion (3 to 4 mg); (3) combined cervical vagal stimulation in the presence of physostigmine; and (4) isoproterenol infusion, titrated to increase the sinus rate by 25%.
To exclude M 2 R desensitization as a cause of the decrease in vagal-induced ERP shortening, we also assessed for ERP shortening by direct application of carbachol (1 mmol/L), a nonselective muscarinic receptor (MR) agonist, to the PLA. On finishing this in vivo portion of the study, the hearts were removed for pathological analysis.
Effective Refractory Periods
To test the autonomic effects on refractoriness, ERPs were obtained from 5, 6, and 4 sites on the PV, PLA, and LAA plaque, respectively, during each autonomic intervention.
AF Sustainability and Dominant Frequency
AF induction was attempted in the LAA during baseline, with atropine, and with double autonomic blockade. This protocol consisted of burst pacing at a cycle length of 180 ms to 100 ms (with 10 ms decrements) for 10 seconds at each cycle length. Current was set at ϫ4 the threshold for capture. The maximum durations of the AF episodes induced by the burst pacing were calculated for each intervention.
Electrograms recorded during the maximum duration AF episodes obtained by burst pacing were analyzed with dominant frequency (DF) analysis. This analysis was performed offline using Matlab (Mathworks, Natick, MA). Four 4-second segments (16 seconds total) of each channel and AF episode after a stabilization period of four seconds after the cessation of burst pacing were selected for analysis.
Activation Mapping
Recordings from the plaques on the PLA and LAA were made during pacing at a cycle length of 400 ms from the left inferior PV at baseline, parasympathetic blockade, and sympathetic blockade. Activation from the PVs was not analyzed because of insufficient signal quality in the majority of these sites. Creation of activation maps from these recordings and the subsequent analysis were performed offline using custom software programmed in Matlab.
We quantified the similarity of activation patterns between 2 autonomic conditions by calculating the Pearson correlation coefficient between 2 beats, with each beat consisting of activation times obtained by a single multi-electrode plaque. A correlation coefficient of 1 would signify identical activation patterns between a beat at baseline and a beat during autonomic blockade. A correlation coefficient near zero would signify significant change. Correlation coefficients between 2 repeated beats at baseline and 2 repeated beats during autonomic blockade were calculated to assess stability of the activation maps. We hypothesized that the similarity in activation patterns between a baseline beat and an autonomic blockade beat would be less than that between 2 repeated baseline beats. We also hypothesized that the similarity between a baseline beat and an autonomic blockade beat would be different between normal dogs and heart failure dogs. An example of an activation map construction and reproducibility analysis are presented in the online-only Data Supplement ( Figure 2 ).
Immunohistochemistry
Immunohistochemistry was performed to examine the size and distribution of the parasympathetic (AChE) and sympathetic (dopa-mine ␤-hydroxylase) nerves in the atria. As explained in the expanded Methods section (online-only Data Supplement), immunostaining was performed on serial sections taken from the PLA, PVs, and LAA. Cardiac ganglia were defined as nerve bundles containing 1 or more neuronal cell bodies. Quantification was performed manually with a light microscope. Mean densities (number per mm 2 ) of nerve bundles and cardiac ganglia cells were quantified using 1ϫ1 mm grids at ϫ10 magnification. We also counted the number of parasympathetic and sympathetic fibers within individual nerve bundles. Sizes of nerve bundles were quantified using rectangular 1ϫ1-mm grids at ϫ20 magnification.
Densities of Muscarinic and ␤-Adrenergic Receptors
Radioligand binding assays were used to determine densities of MRs and ␤-adrenergic receptors (␤ARs) in PV, PLA, and LAA tissue samples. The frozen samples were first powdered and membranes prepared as previously described. 16 The ␤AR binding assays were performed as described in the online-only Data Supplement.
AChE Activity
The activity of AChE was determined in PV, PLA, and LAA tissue samples. Frozen tissue samples (0.05 g) were solubilized and homogenized as described above. Sample supernatants were aliquoted into 96-well microplates and assayed for acetylcholinesterase activity via QuantiChrom Acetylcholinesterase Assay kit (Ellman method) according to the manufacturer's instructions for tissue assay.
Data Analysis
All values are expressed as meanϮstandard error. For most analyses, comparisons between CHF and normal dogs were performed with 2-way mixed ANOVA with 1 within-dog factor (PV versus PLA versus LAA) and 1 between-dogs factor (CHF versus normal). Student t tests were used for post hoc testing. Full factorial mixed effects design with measurement site (PV versus PLA versus LAA) as within-dog variable and presence of CHF as a between-dogs variable was used to analyze the ERP data separately for each of the study stages (baseline, atropine, propranolol, etc). For the physostigmine analysis, physostigmine was also used as a repeated withindogs variable. To test the effect of autonomic blockade on the correlation coefficients of activation times, repeated-measures ANOVA was used. AF duration between interventions was compared using the Student t test. Statistical significance was taken at probability values Ͻ0.05.
Results
The breakdown of sample sizes for each intervention/analysis is listed in the Table. The tissue and molecular assay data are presented first, followed by the in vivo electrophysiological data.
Immunohistochemistry

Qualitative Observations
Nerve bundles were found to be predominately located in the fibrofatty tissue overlying the epicardium ( Figure 1A .i and 1A.ii) in both CHF and normal dogs. Nerve bundles contained either neuronal cells (cardiac ganglia) and/or nerve fibers that arose from the ganglion cells (nerve trunks). Figure  1A .iii shows an example of cardiac ganglia in the PLA; parasympathetic nerve fibers are seen to arise from one of the ganglia (left-sided ganglion). Figure 1A .iv shows an example of a ganglion and a nerve trunk side by side. Sympathetic and parasympathetic nerves were found to be colocalized inside the bundles of both the CHF and normal dogs with the amount of parasympathetic fibers dominating over the sympathetic fibers ( Figure 1A .i through 1A.v). Figure 1A .v shows an example of a grid over a nerve bundle at ϫ20 magnification. Nerve bundle and nerve fiber density for the PV, PLA, and LAA for the CHF and normal dogs are shown in Figure 1B .i. Nerve bundle density in the PLA was significantly greater than in the PV and LAA. Nerve bundle density was significantly higher in CHF dogs than in normal dogs in the LAA but not in the PV and PLA. Nerve bundle size was significantly larger in the PLA of CHF than of normal dogs ( Figure 1B .ii). In addition, the number of parasympathetic fibers/nerve bundle was significantly increased with CHF in the PLA (Figure 1B .iii). The number of sympathetic fibers/nerve bundle did not significantly change with CHF ( Figure 1B .iv). Nerve fiber density within nerve bundles was not analyzed in the LAA because of the very low bundle count in that region. CHF significantly increased the density of cardiac ganglia in the PLA (Figure 1B.v) . The number of cell bodies within each ganglion showed a small but nonsignificant increase ( Figure 1B .vi). Sympathetic nerve fiber density was significantly increased in the PV ( Figure  1B .vii). There was no significant change in parasympathetic nerve fiber density in either the PV or PLA (Figure 1B .viii).
Quantitative Analysis
␤-AR and Muscarinic Acetylcholine Receptor Densities
␤1-AR density was increased in the PLA with CHF ( Figure  2A) but not in the PV and LAA. There was no change in ␤2-AR density with CHF in any region ( Figure 2B ). There was no detected change in MR density with CHF in any region ( Figure 2C ).
Acetylcholinesterase Activity
Because immunostaining for parasympathetic nerves showed a significant increase in AChE caused by an increase in parasympathetic nerve bundle size and ganglion density, we also assessed for AChE activity in the left atrium. As shown in Figure 2D , CHF increased AChE activity in the PV, PLA, and with a trend in the LAA.
Effective Refractory Periods
Baseline At baseline, the ERPs in CHF dogs were significantly longer than in normal dogs in all regions ( Figure 3A ).
Autonomic Blockade
ERP increase caused by propranolol was significantly greater in CHF dogs than in normal dogs in the PV ( Figure 3B ). ERP increase with atropine was significantly less in CHF compared with normal dogs in the PLA and LAA ( Figure 3C ). ERP increase with double blockade (atropine and propranolol) was not different between CHF and normal dogs in any region ( Figure 3D ).
Autonomic Stimulation
ERP shortening caused by ␤-adrenergic stimulation with isoproterenol was not significantly different between CHF and normal dogs (online-only Data Supplement Figure 3 ). ERP shortening caused by vagal stimulation was significantly less in CHF than in normal dogs in all 3 regions ( Figure 3E ). Because immunostaining showed a significant increase in AChE in CHF atria (see Immunohistochemistry section above) and previous data have shown that changes in AChE activity in the synaptic cleft can contribute to vagal desensitization in the heart, we reassessed vagal effect on ERPs after infusion of physostigmine, an AChE inhibitor. The shortening of CHF ERPs as the result of vagal stimulation was significantly increased after infusion of physostigmine ( Figure 3F ), with ERP shortening being equivalent to that noted in normal animals ( Figure 3E ). In contrast, physostigmine infusion did not significantly affect vagal-induced ERP shortening in normal animals (see online-only Data Supplement Figure 4 ). Taken together, the AChE expression/activity data presented in the previous section and the electrophysiology data presented in this section indicate that vagal-induced ERP shortening is significantly attenuated in the CHF left atrium as the result of an increase in AChE activity (in CHF). AChE inhibition restores vagal-induced ERP shortening to normal levels. To exclude M 2 R desensitization as a cause of the decrease in vagal-induced ERP shortening, we also assessed for ERP shortening by direct application of carbachol, a nonselective MR agonist, to the PLA. Carbachol application on the CHF PLA also resulted in ERP shortening that was equivalent to that noted in normal dogs (see online-only Data Supplement Figure 5 ).
AF Duration
The AF duration results are shown in Figure 4A . The maximum duration of AF episodes induced in these dogs was significantly shorter during parasympathetic blockade with atropine than during baseline. Maximum AF duration with double blockade was also shorter than during baseline. There was no significant effect on AF duration after adding propranolol to atropine than with atropine alone.
AF Dominant Frequency
The DF results of the maximum duration AF episodes are shown in Figure 4B . There was no significant difference in mean DF between baseline and with atropine. However, the addition of propranolol to atropine significantly reduced the DF. Figure 4C shows examples of electrograms from the PLA and the corresponding power spectrum and DF for baseline, atropine, and double blockade. The electrograms with double blockade were slower and more organized in this figure.
Activation Mapping
Two paced beats obtained at baseline and 2 beats obtained in the presence of atropine/propranolol were used to analyze the parasympathetic/sympathetic effect on activation maps in the PLA and LAA of CHF and normal dogs. Reproducibility results are presented in the online-only Data Supplement.
Correlation coefficients were significantly less when baseline maps were correlated with atropine maps in both normal ( Figure 5A .i) and CHF dogs ( Figure 5A .ii) compared with the correlation coefficients from repeated beats. This indicates a significant change in activation with atropine. Propranolol caused a similar change in activation ( Figure 5B .i and 5B.ii). The correlation coefficients between baseline and atropine maps were not different in the CHF PLA and LAA than in the normal PLA and LAA ( Figure 5A .iii), suggesting that parasympathetic effect on activation is maintained in CHF. However, the correlation coefficients between baseline and propranolol maps were significantly less in both the CHF PLA and LAA than in the normal PLA and LAA ( Figure  5B .iii), suggesting an enhanced sympathetic effect on conduction with CHF in both these regions. Figure 5A .iv and 5B.iv show examples of a PLA activation map of a CHF dog during baseline and the altered activation map after atropine and propranolol, respectively.
Discussion
Summary of Results
The main findings of this study are that in CHF, both parasympathetic and sympathetic remodeling occur in the left atrium, with an increase in both parasympathetic and sympathetic innervation. Notably, neural remodeling was more pronounced in the PLA and PVs than in the rest of the left atrium. Evidence of sympathetic remodeling was an increase in sympathetic nerve fiber density and a concomitant increase in ␤1-AR. This was accompanied by an increase in sympathetic responsiveness in the PLA and PV, as evidenced by an increase in ERP responsiveness and an enhanced effect on conduction characteristics of these regions. Parasympathetic remodeling was more complex. There was a pronounced increase in parasympathetic innervation, with an increase in nerve bundle size, number of parasympathetic fibers/bundle, cardiac ganglia density, and the number of cell bodies in the ganglia. Vagal hyperinnervation was accompanied by an increase in AChE activity and a decrease in vagal ERP responsiveness in the left atrium. The increased AChE activity probably represents a compensatory response to vagal hyperinnervation. However, this apparent synaptic compensation was only partial, as parasympathetic contribution to conduction/activation was maintained in the left atrium. Most importantly, parasympathetic blockade led to a significant decrease in AF duration, indicating that parasympathetic activity is an important contributor to AF substrate in CHF. Whereas double autonomic blockade did not result in a further decrease in AF duration, it did decrease AF dominant frequency, thus indicating the additional influences of sympathetic activity on AF characteristics. Figure 6 summarizes the results of this study and proposes a working model of how autonomic remodeling in CHF may contribute to the creation of AF substrate.
Dynamic Versus Fixed Substrate for AF
Adequate electrophysiological substrate for AF may be characterized by areas of short refractory periods and slow conduction, and in particular, heterogeneity in repolarization or conduction. 5 In addition to alterations in the ion channel and gap junction expression that occur in AF, 17 structural abnormalities also contribute to the electrophysiological changes that are necessary for the genesis and maintenance of AF. An important structural abnormality that has been studied extensively for its role in creating electrophysiological abnormalities in the atrium is fibrosis. Fibrosis promotes heterogeneity of conduction and pathways facilitating microreentry and macroreentry. 5 Our findings suggest that autonomic remodeling may also play a significant role in the creation of AF substrate. It appears that whereas fibrosis may lead to conduction heterogeneity in the atrium and create a fixed substrate for reentry and consequent AF, parasympathetic and sympathetic remodeling in the PLA and PVs contribute to a more dynamic AF substrate that is dependent on the autonomic state of the left atrium. In fact, even after 3 weeks of rapid ventricular pacing-which typically leads to marked fibrosis in the left atrium 18 -autonomic blockade led to a significant reduction in duration of AF, thereby indicating an important role for the autonomic remodeling in the maintenance of AF. The likely synergism between fibrosis and parasympathetic effect on the creation of AF substrate is as shown in the schematic model proposed in Figure 6 .
Relative Role of Sympathetic Versus Parasympathetic Remodeling in Creating AF Substrate in Heart Failure
Clinical studies suggest that at least in some patients, the sympathetic and/or the parasympathetic nervous system play a role in the genesis of AF. 19, 20 Autonomic fluctuations before the onset of AF have been recognized in several studies. Earlier studies suggested that exerciseinduced AF may be sympathetically driven. In contrast, the parasympathetic nervous system may contribute AF in young patients without structural heart disease, for example, vagal AF. 19 The physiological studies conducted by Patterson et al 21 suggest that adrenergic influences may be playing an important modulatory role in creating adequate substrate for AF, helping provide a necessary "catalyst" for the emergence of focal drivers in the presence of an increased vagal tone.
The results from our study support the notion that the parasympathetic nervous system is the dominant autonomic limb contributing to AF in CHF, with the sympathetic system playing a more modulatory role. Neural remodeling was characterized by increased nerve bundle size and cardiac ganglia density, both of which primarily consist of parasympathetic nerves. Parasympathetic blockade also significantly shortened the duration of AF. A more modulatory role for the sympathetic system is supported by the observation that double autonomic blockade had no addition affect on AF duration but instead significantly decreased dominant frequency of AF compared with parasympathetic blockade alone.
Our findings clearly highlight the importance of the parasympathetic nervous system in establishing AF substrate in the setting of CHF. However, previous studies have suggested that there is a decrease in parasympathetic tone (which accompanies an increase in sympathetic tone) in CHF, as indicated by a decrease in heart rate variability. 22 It must be remembered however, that heart rate variability is a measure of autonomic modulation on the sinus node and does not reliably quantify sympathetic and parasympathetic activity. 23 Our study therefore sheds important new light on the autonomic changes induced in this CHF model and their role in genesis of AF. 
Differences in Parasympathetic and Sympathetic Remodeling in the Atrium Versus the Ventricle in the Setting of Heart Failure
The sympathetic nervous system appears to promote both atrial and ventricular fibrillation. On the other hand, the parasympathetic nervous system is protective against ventricular fibrillation 24 but is profibrillatory in the atrium, both in normal hearts 25 as well as in CHF (as shown in the current study). This difference is in part due to a differential effect of parasympathetic stimulation on atrial and ventricular repolarization. Parasympathetic stimulation significantly shortens action potential duration in the atria but either lengthens it 26 or shortens it by a significantly smaller amount in the ventricle. 27, 28 One possible explanation for this difference is the heterogeneity of IK Ach (Kir3.1/3.4) expression in ventricular myocytes, with some ventricular myocytes having little or no IK Ach . 29 In contrast, as we have recently shown, most atrial myocytes-at least in normal hearts-appear to have IK Ach (as demonstrated their sensitivity to acetylcholine and tertiapin Q. 16 Our study also shows that unlike in the failing ventricle, 13, 14, 30 where there is a downregulation of ␤-receptors in the ventricle, there is an upregulation of both sympathetic nerves and ␤-receptor binding in the CHF atrium (with an accompanying increase in sympathetic responsiveness). The increase in sympathetic innervation that we demonstrate in our model is consistent with that previously noted in human AF. 31 Differences in sympathetic remodeling between the atrium and ventricle may be attributed at least in part to CHF being typically more severe in the studies evaluating ventricular autonomic remodeling. 13, 14 Preferential Autonomic Remodeling in the PLA/PVs: Therapeutic Implications of Current Findings
Our previous work in normal hearts has shown that the PLA and the PVs have a unique autonomic profile compared with other areas of the atrium. 9, 16, 32 Interestingly, in the current study, the greatest changes in autonomic innervation and related autonomic responsiveness in the setting of CHF were also localized to the PVs and PLA, thus underscoring the importance of this region in the genesis and maintenance of AF, especially in the setting of CHF.
These findings have important implications on the treatment of AF in the setting of CHF. Catheter ablation in and around the PV and PLA has recently emerged as a viable therapy for focal AF. However, in patients with structural heart disease, for example, CHF, significantly more extensive ablation has to be performed to increase "cure" rates for AF. Yet, success rates in the setting of structural heart disease do not appear to exceed 50% to 60%. 33 Our study indicates that the autonomic nervous system contributes to the creation of AF substrate, with the parasympathetic nervous system being involved in the maintenance of AF and the sympathetic nervous system affecting the frequency characteristics of AF. Targeted approaches to selectively interrupt autonomic signaling in the PLA may therefore help increase the success rates of current ablative or surgical therapies for AF. We have recently shown that inhibition of G i -the G-protein responsible for downstream parasympathetic signaling in the atrium-by novel G␣ i C-terminal inhibitory peptides can allow selective parasympathetic inhibition in the left atrium, with a resulting decrease in vagal-induced AF in normal canine hearts. 16 A similar G-protein-targeted approach can be used to selectively inhibit parasympathetic and/or sympathetic signaling in the atrium in the setting of CHF.
Limitations
The time course over which autonomic remodeling occurs was not studied. Thus, it is unknown whether the autonomic remodeling begins shortly after the initiation of pacing or only after structural remodeling has taken place. Furthermore, we did not systematically study the correlation between the echocardiographic/clinical parameters and the extent of autonomic remodeling. The mechanism of burst pacing-induced AF may be different from spontaneous clinical AF (spontaneous AF was not observed in this study). Because parasympathetic tone is higher in dogs than in humans and the duration of induced CHF is relatively brief, the degree to which these conclusions can be extrapolated to human CHF is as yet undefined. Interpretation of the atrial response to propranolol and atropine may be complicated by the sympathovagal interactions that occur with autonomic blockade. Autonomic remodeling in the right atrium and in the ventricles was not assessed in this study.
Conclusions
A multifaceted approach was used to demonstrate autonomic remodeling of the atria caused by CHF. Further study is necessary to determine whether targeted autonomic blockade in the PLA is capable of inhibiting AF in the setting of CHF.
